【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Biosimilar Monoclonal Antibodies
1.2 Why You Should Read This Report
1.3 How This Study Delivers
1.4 Main Questions Answered by the Analysis
1.5 Who Is This Investigation For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Biosimilar Monoclonal Antibodies
2.1 Natural Antibodies: Key to the Immune System
2.2 From Serum Therapy to Monoclonal Antibodies (MAbs)
2.3 Humanising the MAb
2.4 Biologics (Biological Drugs) and Biosimilars
2.5 Why are Biosimilars in High Demand?
2.6 Considerations for the Development of Biosimilars
2.6.1 Biologics and Biosimilars Are Large, Complex Molecules
2.6.2 How Much a Concern is Immunogenicity?
2.7 Biosimilar Monoclonal Antibodies on the Market
3. World Market Prospects for Biosimilar Monoclonal Antibodies, 2015-2025
3.1 The World Market for Biosimilar Monoclonal Antibodies, 2013- 2014: Three Biosimilar MAbs on Sale
3.2 The World Market for Biosimilar MAbs: An Overarching Revenue Forecast, 2014-2025
3.3 The World Market for Biosimilar MAbs by Compound: Revenue and Market Share Predictions, 2019 and 2025
3.4 The World Market for Biosimilar MAbs by Compound: Revenue Forecasts, 2014-2025
3.4.1 Will Biosimilar Versions of Monoclonal Antibodies Capture a Large Proportion of the Market?
3.4.2 Biosimilar Infliximab: High Growth Expected
3.4.2.1 Biosimilar Infliximab: Revenue Forecast, 2015-2025
3.4.3 Biosimilar Rituximab: With Many Compounds Under Development, Will Sales Growth be Driven or Restrained?
3.4.3.1 Biosimilar Rituximab: Revenue Forecast, 2015-2025
3.4.4 Biosimilar Abciximab: Low Market Incentive Means Few Compounds in Development
3.4.4.1 Biosimilar Abciximab: Revenue Forecast, 2015-2025
3.4.5 Biosimilar Trastuzumab: The 4th Biosimilar MAb to Enter the Market
3.4.5.1 Biosimilar Trastuzumab: Revenue Forecast, 2015-2025
3.4.6 Biosimilar Adalimumab: Great Incentive to Develop Biosimilar Versions of the Leading Drug of 2013 & 2014
3.4.6.1 Biosimilar Adalimumab: Revenue Forecast, 2015-2025
3.4.7 Biosimilar Bevacizumab: Will Late Entry to the Market Restrict Revenue Generation?
3.4.7.1 Biosimilar Bevacizumab: Revenue Forecast, 2015-2025
3.5 Large Market Potential to Drive Growth to 2025
3.6 What Will Restrain Expansion of the Biosimilar MAbs Market Between 2013 and 2025?
4. Promising Biosimilar MAb Products and Their Predicted Future Successes, 2015-2025
4.1 Biosimilar Versions on the Market: Remsima Dominated in 2013
4.1.1 Celltrion’s Remsima / Hospira’s Inflectra / Egis’ Flammegis (infliximab): The First Official Biosimilar Monoclonal Antibody
4.1.2 Dr. Reddy’s Reditux (rituximab): Are US and EU Approval Expected?
4.1.3 Isu Abxis’ Clotinab (abciximab): The First Biosimilar Monoclonal Antibody?
4.1.4 Instas Pharmaceuticals’ Mabtas (Rituximab)
4.1.5 Reliance Life Sciences’ AbcixiRel (abciximab)
4.1.6 Probiomed’s Kikuzubam (rituximab): Registration Revoked, Reports Suggest
4.2 Biosimilar Versions on the Market and Promising Compounds in the R&D Pipeline: Revenue Forecasts, 2015-2025
4.2.1 Celltrion’s Remsima / Hospira’s Inflectra / Egis’ Flammegis (infliximab): Revenue Forecast, 2015-2025
4.2.2 Epirus Biopharmaceuticals’ Infimab (infliximab): Revenue Forecast, 2014-2025
4.2.3 Dr. Reddy’s Reditux (rituximab): Revenue Forecast, 2015-2025
4.2.4 Intas Pharmaceuticals’ Mabtas (rituximab): Revenue Forecast, 2015-2025
4.2.5 BIOCAD’s AcellBia (rituximab): Revenue Forecast, 2015-2025
4.2.6 Boehringer Ingelheim’s BI695500 (rituximab): Revenue Forecast, 2015-2025
4.2.7 Celltrion’s CT-P10 (rituximab): Revenue Forecast, 2015-2025
4.2.8 Isu Abxis’ Clotinab (abciximab): Revenue Forecast, 2015-2025
4.2.9 Reliance Life Sciences’ AbcixiRel (abciximab): Revenue Forecast, 2015-2025
4.2.10 Biocon and Mylan’s CANMAb/Hertraz (trastuzumab): Revenue Forecast, 2015-2025
4.2.11 Celltrion’s Herzuma (trastuzumab): Revenue Forecast, 2015-2025
4.2.12 BIOCAD’s BCD-022 (trastuzumab): Revenue Forecast, 2015-2025
4.2.13 Boehringer Ingelheim’s BI695501 (adalimumab): Revenue Forecast, 2015-2025
4.2.14 Fujifilm Kyowa Kirin Biologics’ FKB327 (adalimumab): Revenue Forecast, 2015-2025
4.2.15 BIOCAD’s BCD-021 (bevacizumab): Revenue Forecast, 2015-2025
4.2.16 Fujifilm Kyowa Kirin Biologics’ FKB238: Revenue Forecast, 2015-2025
5. Leading National Markets for Biosimilar Monoclonal Antibodies, 2015-2025
5.1 What Were the Leading National Markets for Biosimilar Monoclonal Antibody Development in 2013?
5.2 What Were the Leading National Markets for Sales of Biosimilar Monoclonal Antibodies in 2013?
5.3 Which Markets Will Grow Fastest to 2025?
5.4 Market Shares of the Leading National Markets: All Set to Change, 2015-2025
5.5 South Korea: The World’s Leading Nation for Biosimilar MAbs
5.5.1 KFDA Introduced Biosimilar Guidelines in 2009
5.5.2 Significant Investment in Biosimilars in South Korea
5.5.3 Outlook for the South Korean Biosimilar MAb Market, 2014-2025
5.6 The Outlook for Monoclonal Antibody Biosimilars in China, 2015-2025
5.6.1 China to Release Formal Biosimilar Development Guidelines
5.6.2 China: Becoming the World’s Leading Market for Biosimilar MAbs
5.7 Brazil: The Third Leading Country in the 2013 Biosimilar MAb Market, But What Does The Future Hold?
5.7.1 ANVISA’s Biosimilar Regulations Are Similar to the EMA’s
5.7.2 Outlook for Monoclonal Antibody Biosimilars in Brazil, 2015-2025
5.8 Outlook for Monoclonal Antibody Biosimilars in India, 2015-2025
5.8.1 India Releases New Biosimilar Development Guidelines
5.8.2 Indian Biosimilars Submarket Forecast 2015-2025
5.9 The Outlook for Biosimilar MAbs in the US, 2015-2025
5.9.1 When Are the Final FDA Biosimilar Guidelines Expected?
5.9.2 Legal Challenges for Biosimilars in the US
5.9.3 State Regulation of Biosimilar Substitution
5.9.4 The US Biosimilar MAb Market: Revenue Forecast, 2015-2025
5.10 The Outlook for Monoclonal Antibody Biosimilars in Japan 2015-2025
5.10.1 Regulatory Processes for Biosimilars in Japan
5.10.2 Regulations for Naming Biosimilars
5.10.3 Biosimilar MAbs to be Launched in Japan in 2016
5.10.4 Japanese Biosimilar Submarket Forecast 2015-2025
5.11 The Outlook for Monoclonal Antibody Biosimilars in the EU, 2015-2025
5.11.1 The EU Led the World in Biosimilar Regulation
5.11.2 Updating Biosimilar Regulation: Guidelines for the Specific Approval of Biosimilar MAbs
5.11.3 EMA Simplifies Biosimilar Development in the EU
5.11.4 Biosimilar MAbs in the EU5 Countries: Revenue Forecasts, 2015-2025
5.11.5 Germany: Set to Become the Largest National Market for Biosimilar MAbs in the EU
5.11.6 France: Will the Uptake of Biosimilar MAbs Be Restricted?
5.11.7 UK: Drug Uptake Will Be High
5.11.8 Italy: Healthcare Spending Cuts Will Drive Growth
5.11.9 Spain: High Biosimilar MAb Discounts Expected
5.12 The Outlook for Monoclonal Antibody Biosimilars in Russia, 2015-2025
5.12.1 No Specific Biosimilar Legislation Exists in Russia, 2014
5.12.2 Russian Government Investing in Development of Biosimilars
5.12.3 Russian Biosimilar MAb Revenue Forecast 2015-2025
6. Leading Companies for Developing and Producing Biosimilar MAbs
6.1 Prominent Companies in the Biosimilar Monoclonal Antibodies Industry, 2014
6.2 Collaboration in Biosimilar MAb Development
6.3 BioXpress: 16 Compounds in the R&D Pipeline
6.4 Celltrion: One Compound on the Market and Two in Phase III of Development, and Others Wait In The Wings
6.5 Harvest Moon: Six Compounds Under Development
6.6 Genor Biopharma: Five Compounds in Development
6.7 Mabion: Poland’s Leading Biosimilar MAb Developer
6.8 Gene Techno Science: Three Compounds Under Development
6.9 India’s Biocon: A Quiet Competitor
6.10 Pfizer: Entering the Biosimilar MAbs Industry and Market
6.11 BIOCAD: Company Based in Russia
6.12 Big Pharma and the Biosimilar MAbs Market
7. Qualitative Analyses of the Biosimilar MAbs Market, 2015-2025
7.1 Strengths and Weaknesses of the Biosimilar Monoclonal Antibody Market, 2014
7.1.1 Worldwide Demand for More-Affordable Therapies Underpins that Market
7.1.2 Complexity of Protein Molecules Gives Technical Challenges
7.2 Opportunities and Threats Facing the Biosimilar Monoclonal Antibody Market, 2015-2025
7.2.1 A Well-Stocked Pipeline in the Face of Approaching Patent Expiries: Opportunities for Market Expansion
7.2.2 Competition and Lack of Confidence: Threats to Market Penetration?
7.2.2.1 Biobetters as a Threat to Biosimilars
7.3 Social, Technological, Economic and Political Forces Influencing the Biosimilar Monoclonal Antibodies Market (STEP Analysis) 2015-2025
7.3.1 Social Factors: Driving or Restraining the Market?
7.3.2 Advances in Technology: Producing Biosimilar MAbs Cheaply and Easily
7.3.3 Economic Pressures Raise Demand for Biosimilar MAbs
7.3.4 Political Issues: Stringent Regulations Hurdles to Market Entry
8. Research Interviews from Our Survey
8.1 Interview with Bruce Burnett
8.1.1 On Regulations for and Testing of Biosimilars
8.1.2 On Drivers and Restraints for Biosimilar MAbs
8.1.3 Biosimilars and Immunogenicity
8.1.4 On Biosimilars and Research
8.2 Interview with Dr Corrine SinQuee-Brown, The Cancer Center Bahamas
8.2.1 On Biosimilar MAbs in The Bahamas
8.2.2 On Drivers and Restraints for Biosimilar MAbs
8.3 Interview with Dr Xing Wang, President of Array Bridge
8.3.1 On Challenges Surrounding the Development of Biosimilar MAbs
8.3.2 On the Services Offered by Array Bridge
8.3.3 On the Demand for Biosimilar MAbs
8.3.4 On Factors Determining the Success of Biosimilar MAbs
8.3.5 On Regulatory Approval of Biosimilar MAbs: The US vs. the EU
8.4 Interview With Dr Terence Ryan, SVP, iBio
8.4.1 iBio and its Biosimilar Pipeline, 2013
8.4.2 The iBioLaunch Platform
8.4.3 Differences Between Developing Biosimilar and Biologics
8.4.4 Product Differentiation in the Biosimilar Market
8.4.5 Biosimilars and Immunogenicity
8.4.6 Challenges in Developing Biosimilars for the US Market
9. Conclusions from the Research and Analysis
9.1 Biosimilar Monoclonal Antibodies: World Market, 2015-2025
9.2 The Future of Top Compounds in Development and Testing
9.3 Leading National Markets for Biosimilar Monoclonal Antibodies, 2015-2025
9.4 Leading Companies in the Industry
9.5 Trends in the Industry and Market
9.5.1 Economic Pressures Stimulate Demand for Therapeutic MAbs
9.5.2 Patent Expiries of Several Blockbuster MAbs Are Approaching, Creating Large Opportunities for Biosimilars
9.5.3 Complexity of the Molecules Make Production Challenging
9.5.4 Doctor and Patient Doubt Regarding Interchangeability Will Restrict Uptake
9.5.5 Do Biobetters Pose a Threat?
【レポート販売概要】
■ タイトル：バイオシミラー・モノクローナル抗体（MAb）の世界市場■ 英文：Biosimilar Monoclonal Antibodies: World Industry and Market Outlook 2015-2025
■ 発行日：2015年1月
■ 調査会社：visiongain
■ 商品コード：VGAIN5020406
■ 調査対象地域：世界
- カタラーゼの世界市場Catalase (CAS 9001-05-2) Market Research Report 2014 presents comprehensive data on catalase markets globally and regionally (Europe, Asia, North America etc.) The report includes catalase description, covers its application areas and related patterns. It overviews catalase market, names catalase producers and indicates its suppliers. Besides, the report provides catalase prices in regional market …
- 電気生理学装置の世界市場予測2017-2026：モニタリング装置（心エコー検査、診断用カテーテル、ホルター心電計、イベントモニター）および治療装置（ペースメーカー、ICD、アブレーションカテーテル、CRT-Ds、CRT-P）の収益予測Electrophysiology Devices – our new study reveals trends, R&D progress, and predicted revenues Where is the electrophysiology devices market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 147-page …
- ウエルネス旅行の世界市場2016-2020About Tourism People traveling to domestic or foreign locations and staying for not more than one consecutive year for business, leisure, and other purposes are defined as tourists. Tourism is one of the major sources of income for many countries. It positively affects the economy of both the source and host countries. Technavio’s analysts forecast the global wellness tourism market to grow at a C …
- ビタミンD試験の世界市場分析：試験タイプ別（25-ヒドロキシビタミンD試験; 1,25-ジヒドロキシビタミンD試験）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA）、セグメント予測、2014-2025The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in geriatric population as well as cases of chronic illnesses is likely to drive the market during the forecast period. Furthermore, increase in investment for development and commercialization of various accurate, innovative, and easy-to-use test …
- モバイルアプリケーション及びウィジェット（Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Fifth Edition）Mobile Applications and Widgets: Portable Applications on Mobile Platforms, Fifth Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is defined through current market statistical data, financial an …
- 極低温断熱材の世界市場予測（～2023年）“Rising demand for liquefied natural gas as fuel is expected to drive the cryogenic insulation market.”The cryogenic insulation market is estimated to be USD 2.3 billion in 2018 and is projected to reach USD 3.3 billion by 2023, at a CAGR of 7.20% between 2018 and 2023. The cryogenic insulation market is largely driven by the rising demand for liquefied natural gas as fuel. Transportation and stor …
- 固定衛星サービス（FSS）の世界市場2015-2019About fixed satellite service A fixed satellite service or FSS uses geosynchronous satellites for broadcasting purposes such as TV and radio, telecommunications, and satellite communication that are used by government, military organizations, small and large enterprises, and other end-users. FSS provides valuable source information to national intelligence and security organizations to fight crime …
- 不妊治療サービスの米国市場2017-2021About Infertility Services Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Technavio’s analysts forecast the infertility serv …
- 動物用抗感染薬の世界市場2015-2022According to Stratistics MRC, the Veterinary Anti-infectives market is accounted for $4.79 billion in 2015 and is expected to reach $9.11 billion by 2022 growing at a CAGR of 9.6% from 2015 to 2022. Growing zoonotic and foodborne diseases and greater livestock production are the key factors fueling the market growth. Increased competition for cultivated land and cost effective production are the m …
- BRIC（ブラジル/ロシア/インド/中国）の気管支鏡（医療機器）市場BRIC Bronchoscopes Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Bronchoscopes Market Outlook to 2020", provides key market data on the BRIC Bronchoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Video Bronchoscopes (Flexible Video Bronchoscopes and Portable Video Bronchoscopes) and N …
- ポリテトラフルオロエチレン（PTFE）メンブレンの世界市場2019-2023About this market Industrial growth in emerging countries will drive the growth of the market. There has been a growing focus on domestic manufacturing in several emerging countries to meet the growing internal demand for industrial and consumer goods to reduce the dependence on imports. Rising public and private investment in the industrial sector will boost the demand for PTFE membranes as they …
- LiDAR（ライダー）の世界市場：航空用ライダー、地上用ライダーAbout LiDAR LiDAR stands for Light Detection and Ranging. It is a technology to generate precise and spatial information about a particular object. The technology works on the principle of reflection where focused beam of light is emitted and then detected by the sensor after reflecting from the object and the time taken for the process is measured. This data is used to calculate the distances to …
- 世界の肉（ミート）市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global meat market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global meat market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global meat market …
- フレキシブル電池の世界市場予測（～2022）：種類別（薄膜（リチウムイオン、リチウムポリマー）、プリンテッド、曲面）、充電性別、用途別The flexible battery market is expected to be worth USD 958.4 Million by 2022, at a CAGR of 46.6% between 2016 and 2022. The growth of this market is propelled by the increasing miniaturization of electronics devices, need for thin and flexible batteries in consumer electronics, and the growing demand for wearable devices. The market has been segmented on the basis of type, chargeability, applicat …
- Strike Energy Limited社の石油・ガス開発・生産動向及びコスト分析（2013年）Strike Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Strike Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
